Cargando…
Moderately hypofractionated carbon ion radiotherapy for prostate cancer; a prospective observational study “GUNMA0702”
BACKGROUND: Carbon ion Radiotherapy for prostate cancer is widely used, however reports are limited from single institute or short follow up. We performed a prospective observational study (GUNMA0702) to evaluate the feasibility and efficacy of carbon ion radiotherapy for localized and locally advan...
Autores principales: | Kawamura, Hidemasa, Kubo, Nobuteru, Sato, Hiro, Mizukami, Tatsuji, Katoh, Hiroyuki, Ishikawa, Hitoshi, Ohno, Tatsuya, Matsui, Hiroshi, Ito, Kazuto, Suzuki, Kazuhiro, Nakano, Takashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990498/ https://www.ncbi.nlm.nih.gov/pubmed/32000716 http://dx.doi.org/10.1186/s12885-020-6570-8 |
Ejemplares similares
-
Carbon ion radiotherapy for prostate cancer with bladder invasion
por: Miyasaka, Yuhei, et al.
Publicado: (2021) -
Hypofractionated carbon‐ion radiotherapy for stage I peripheral nonsmall cell lung cancer (GUNMA0701): Prospective phase II study
por: Saitoh, Jun‐ichi, et al.
Publicado: (2019) -
Long-term outcome of hypofractionated intensity-modulated radiotherapy using TomoTherapy for localized prostate cancer: A retrospective study
por: Takakusagi, Yosuke, et al.
Publicado: (2019) -
Colorectal Cancer Screening Outcomes of 2412 Prostate Cancer Patients Considered for Carbon Ion Radiotherapy
por: Kobayashi, Nao, et al.
Publicado: (2021) -
Kinetics of Prostate-Specific Antigen after Carbon Ion Radiotherapy for Prostate Cancer
por: Darwis, Narisa Dewi Maulany, et al.
Publicado: (2020)